Pharmacy Benefit Manager Accountability Study Act of 2021
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Mar 11, 2021)
Pharmacy Benefit Manager Accountability Study Act of 2021
This bill requires the Government Accountability Office to report on the role of pharmacy benefit managers in the pharmaceutical supply chain and recommend legislative actions to lower the cost of prescription drugs. The report must address the use of rebates and fees, the average prior authorization approval time, and the use of step therapy within the 10 largest pharmacy benefit managers.
What just happenedMar 12, 2021
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseMar 11, 2021
- Mar 12, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Mar 11, 2021IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Mar 11, 2021IntroReferralIntro-H
Introduced in House
- Mar 11, 2021IntroReferral1000
Introduced in House